Neuberger Berman Group LLC Ptc Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$41.85 - $53.85 $684,833 - $881,201	16,364 New	16,364 $821,000
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $916,150 - $1.19 Million	-24,141 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $1.84 Million - $2.71 Million	-39,359 Reduced 61.98%	24,141 $1.14 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $113,524 - $142,675	2,500 Added 4.1%	63,500 $2.97 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $255,360 - $329,880	6,000 Added 10.91%	61,000 $3.1 Million
Q4 2019 Feb 12, 2020	BUY	$32.22 - $50.07 $122,436 - $190,266	3,800 Added 7.42%	55,000 $2.64 Million
Q3 2019 Nov 13, 2019	BUY	$33.82 - $48.17 $179,246 - $255,301	5,300 Added 11.55%	51,200 $1.73 Million
Q2 2019 Aug 13, 2019	BUY	$35.42 - $45.0 $881,958 - $1.12 Million	24,900 Added 118.57%	45,900 $2.07 Million
Q1 2019 May 13, 2019	BUY	$28.09 - $39.49 $589,890 - $829,290	21,000 New	21,000 $790,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.